BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36280880)

  • 1. Inclusion body myositis and Sjögren's syndrome: the association works both ways.
    Giannini M; Felten R; Gottenberg JE; Geny B; Meyer A
    Acta Neuropathol Commun; 2022 Oct; 10(1):152. PubMed ID: 36280880
    [No Abstract]   [Full Text] [Related]  

  • 2. A Patient with Sjogren's Syndrome and Subsequent Diagnosis of Inclusion Body Myositis and Light-Chain Amyloidosis.
    Hom J; Marwaha S; Postolova A; Kittle J; Vasquez R; Davidson J; Kohler J; Dries A; Fernandez-Betancourt L; Majcherska M; Dearlove J; Raghavan S; Vogel H; Bernstein JA; Fisher P; Ashley E; Sampson J; Wheeler M;
    J Gen Intern Med; 2019 Jun; 34(6):1058-1062. PubMed ID: 30887439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary Sjögren syndrome and inclusion body myositis].
    Monteiro P; Coutinho M; Salvador MJ; Malcata A
    Acta Reumatol Port; 2009; 34(2A):261-5. PubMed ID: 19474780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic inclusion body myositis and primary Sjogren's syndrome: an overlooked diagnosis.
    Chung SH; Bent EI; Weiss MD; Gardner GC
    Clin Rheumatol; 2021 Oct; 40(10):4089-4094. PubMed ID: 33884496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rare Case of Necrotizing Myopathy and Fibrinous and Organizing Pneumonia with Anti-EJ Antisynthetase Syndrome and SSA Antibodies.
    Kashif M; Arya D; Niazi M; Khaja M
    Am J Case Rep; 2017 Apr; 18():448-453. PubMed ID: 28439062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESS.
    Felten R; Giannini M; Nespola B; Lannes B; Levy D; Seror R; Vittecoq O; Hachulla E; Perdriger A; Dieude P; Dubost JJ; Fauchais AL; Le Guern V; Larroche C; Dernis E; Guellec D; Cornec D; Sibilia J; Mariette X; Gottenberg JE; Meyer A
    Rheumatology (Oxford); 2021 Feb; 60(2):675-681. PubMed ID: 32780813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype.
    Rojana-udomsart A; Needham M; Luo YB; Fabian V; Walters S; Zilko PJ; Mastaglia FL
    Clin Neurol Neurosurg; 2011 Sep; 113(7):559-63. PubMed ID: 21507567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare case of Sjögren's syndrome antibody (SSA-Ro52kDA)-associated interstitial lung disease and myositis with pipe stem capillaries.
    Ramu A; Kaur N; Jain R
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34620633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inclusion body myositis and primary Sjögren syndrome].
    Pardos Gea J; Selva O'Callaghan A; Sans Valeta J; Grau Junyent JM
    Med Clin (Barc); 2003 Mar; 120(8):318-9. PubMed ID: 12636906
    [No Abstract]   [Full Text] [Related]  

  • 10. Inclusion body myositis in association with vitamin B12 deficiency and Sjögren's syndrome.
    Khraishi MM; Jay V; Keystone EC
    J Rheumatol; 1992 Feb; 19(2):306-9. PubMed ID: 1629834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of Sjögren's syndrome and anti-cN1A antibody in myositis patients.
    Levy D; Nespola B; Giannini M; Felten R; Severac F; Varoquier C; Rinagel M; Korganow AS; Martin T; Poindron V; Maurier F; Chereih H; Bouldoires B; Hervier B; Lenormand C; Chatelus E; Geny B; Sibilia J; Arnaud L; Gottenberg JE; Meyer A
    Rheumatology (Oxford); 2022 Feb; 61(2):756-763. PubMed ID: 33974078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion body myositis and Sjogren's syndrome.
    Gutmann L; Govindan S; Riggs JE; Schochet SS
    Arch Neurol; 1985 Oct; 42(10):1021-2. PubMed ID: 2994608
    [No Abstract]   [Full Text] [Related]  

  • 13. The concomitant occurrence of Sjögren's syndrome and polymyositis.
    Gran JT; Myklebust G
    Scand J Rheumatol; 1992; 21(3):150-4. PubMed ID: 1604256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dermatomyositis, Sjögren's syndrome and vasculitis: an infrequent overlapping connective disease].
    Sendino A; Barbado FJ; González-Anglada I; Arribas JR; Vázquez JJ
    Rev Clin Esp; 1992 Nov; 191(7):369-71. PubMed ID: 1475463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and associated comorbidities in inclusion body myositis.
    Naddaf E; Shelly S; Mandrekar J; Chamberlain AM; Hoffman EM; Ernste FC; Liewluck T
    Rheumatology (Oxford); 2022 May; 61(5):2016-2024. PubMed ID: 34534271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of lingual intervention in a patient with inclusion body myositis and Sjögren's syndrome: a longitudinal case study.
    Malandraki GA; Kaufman A; Hind J; Ennis S; Gangnon R; Waclawik A; Robbins J
    Arch Phys Med Rehabil; 2012 Aug; 93(8):1469-75. PubMed ID: 22480545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inclusion body myositis associated with chronic thyroiditis, Sjögren's syndrome and autoimmune cholangitis].
    Hama K; Miwa H; Nishino I; Nonaka I; Kondo T
    No To Shinkei; 2004 Jun; 56(6):503-7. PubMed ID: 15328839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiac involvement in polymyositis--dermatomyositis associated with Sjogren's syndrome].
    Pardo J; Meruane J; Staeding J; Drago G; Etchart M
    Rev Med Chil; 1995 May; 122(5):550-5. PubMed ID: 7724897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-signal recognition particle antibody-positive polymyositis in a patient with Sjögren's syndrome showing various types of annular erythema: Positive correlation between the activities of annular erythema and myositis.
    Kabuto M; Fujimoto N; Hamaguchi Y; Tanaka T
    J Dermatol; 2016 Aug; 43(8):958-61. PubMed ID: 26972113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dermatopolymyositis, Gougerot-Sjögren's syndrome, Hashimoto's thyroiditis and glomerulopathy].
    Fain O; Rainfray M; Callard P; Guillevin L; Meyrier A
    Nephrologie; 1990; 11(4):223-5. PubMed ID: 2074922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.